Search - tctmd.com

Displaying 1 - 20 of 21

Sort: Relevancy | Date

News Conference News TVT 2023

Latest-Generation MitraClip Devices Make Strides Against Residual MR

Shelley Wood

June 09, 2023

News Conference News TVT 2023

Solid Anchoring, Good Echo Results With Transapical TMVR at 2 Years

Michael O'Riordan

June 09, 2023

Presentation TVT 2023

LATE BREAKING INNOVATION: Transcatheter Edge-to-Edge Repair for Tricuspid Regurgitation: Comparing the TRILUMINATE™ Pivotal and bRIGHT Clinical Trials

Presenter: Paul Sorajja

June 09, 2023

News Features TVT 2022

Minorities, Poorer Patients Missing Out on Structural Heart Care

Michael O'Riordan

June 15, 2022

News Conference News TVT 2022

Surgical Explant or Redo for TAVI Failures? Some Registry Insights

Michael O'Riordan

June 10, 2022

News Conference News TVT 2022

Non-COAPT-Like Patients Fare Well With MitraClip, EXPAND Suggests

Michael O'Riordan

June 09, 2022

Presentation TVT 2022

Characteristics of Clinical Trial Sites for Novel Transcatheter Mitral and Tricuspid Valvular Therapies – Inequities in Access to Clinical Trials

Presenter: Ashwin Nathan

June 08, 2022

Presentation TVT 2022

First Report of Outcomes of TEER in Patients With Endocardial Leads: Insights From TRILUMINATE and bRIGHT Clinical Trials

Presenter: Georg Nickenig

June 08, 2022

Presentation TVT 2021

First Report of 2-Year Outcomes With a Next-Generation Left Atrial Appendage Closure Device: Final Results From the PINNACLE FLX IDE Trial

Presenter: Saibal Kar

July 21, 2021

Presentation TVT 2021

Rehospitalization and Mortality in Patients With Heart Failure and Secondary Severe Mitral Regurgitation: The COAPT Trial

Presenter: Gennaro Giustino

July 20, 2021

Presentation TVT 2021

Predictors of Reduction in Mitral Regurgitation by the MitraClip - Durable, Transient, or Failures in the COAPT Trial

Presenter: Scott Lim

July 20, 2021

News Conference News TVT 2020

Device Explants After TAVR Rare but Risky

Michael O'Riordan

June 24, 2020

News Conference News TVT 2020

Real-world, Low-risk Patients Fare Well With Self-Expanding Evolut PRO

Shelley Wood

June 24, 2020

News Conference News TVT 2020

Reduced Leaflet Motion After TAVR: No Link to Impaired Hemodynamics, Events

Michael O'Riordan

June 23, 2020

News Conference News TVT 2020

Sapien 3 in Intermediate Risk: Death or Stroke Similar to SAVR at 5 Years

Michael O'Riordan

June 22, 2020

News Conference News TVT 2020

MitraClip Cuts Death, HF Hospitalization Across NYHA Class: COAPT

Michael O'Riordan

June 21, 2020

News Conference News TVT 2020

Newer TAVR Devices Reassure in Failed Surgical Valves

Shelley Wood

June 20, 2020

News Conference News TVT 2019

Better Hemodynamics, Less Mismatch With Self-Expanding TAVR vs Surgery

Michael O'Riordan

June 20, 2019

News Conference News TVT 2019

Transcarotid Bests Aortic/Apical for Alternative TAVR Access: TVT Registry

Shelley Wood

June 17, 2019

Presentation TVT 2019

Echocardiographic Results of Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients: The PARTNER 3 Trial

Presenter: Philippe Pibarot

June 14, 2019

Advertisement

Latest-Generation MitraClip Devices Make Strides Against Residual MR

Solid Anchoring, Good Echo Results With Transapical TMVR at 2 Years

LATE BREAKING INNOVATION: Transcatheter Edge-to-Edge Repair for Tricuspid Regurgitation: Comparing the TRILUMINATE™ Pivotal and bRIGHT Clinical Trials

Minorities, Poorer Patients Missing Out on Structural Heart Care

Surgical Explant or Redo for TAVI Failures? Some Registry Insights

Non-COAPT-Like Patients Fare Well With MitraClip, EXPAND Suggests

Characteristics of Clinical Trial Sites for Novel Transcatheter Mitral and Tricuspid Valvular Therapies – Inequities in Access to Clinical Trials

First Report of Outcomes of TEER in Patients With Endocardial Leads: Insights From TRILUMINATE and bRIGHT Clinical Trials

First Report of 2-Year Outcomes With a Next-Generation Left Atrial Appendage Closure Device: Final Results From the PINNACLE FLX IDE Trial

Rehospitalization and Mortality in Patients With Heart Failure and Secondary Severe Mitral Regurgitation: The COAPT Trial

Predictors of Reduction in Mitral Regurgitation by the MitraClip - Durable, Transient, or Failures in the COAPT Trial

Device Explants After TAVR Rare but Risky

Real-world, Low-risk Patients Fare Well With Self-Expanding Evolut PRO

Reduced Leaflet Motion After TAVR: No Link to Impaired Hemodynamics, Events

Sapien 3 in Intermediate Risk: Death or Stroke Similar to SAVR at 5 Years

MitraClip Cuts Death, HF Hospitalization Across NYHA Class: COAPT

Newer TAVR Devices Reassure in Failed Surgical Valves

Better Hemodynamics, Less Mismatch With Self-Expanding TAVR vs Surgery

Transcarotid Bests Aortic/Apical for Alternative TAVR Access: TVT Registry

Echocardiographic Results of Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients: The PARTNER 3 Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content